CD8A and neoplasm: In a previous report, the peripheral CD4+/CD8+ T cell ratio was significantly lower in patients with HCC prior to TACE than in healthy volunteers and was increased 1 month after TACE [88,89], although its effect on anti-tumor immunity was not investigated in those studies.